I like your thinking Mozzarc. It will be interesting to see if there is a discernible reaction tomorrow.
I live in Perth and would love to attend, BUT I'm in the Gold Coast on business... Bad luck eh !
I've been researching PAR lately and have dipped a toe in the water. What I'm trying to understand is on 15/4/19 PAR announced that they met their SECONDARY endpoints for the OA Knee trial... but what about the primary endpoint(s) ? They don't seem to have addressed this directly. Is there more information on the primary endpoints still to be released ?
I do like the fact that Paul Rennie bought an additional $49k on-market after this release.
Apologies if this has already been discussed.
research reports and media, page-34
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $97.94M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.0¢ | 28.0¢ | $332 | 1.184K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 15418 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 4970 | 2 |
View Market Depth
| Last trade - 10.06am 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
28.5¢ |
Change
0.000 ( 3.64 %) |
||||
| Open | High | Low | Volume | ||
| 28.0¢ | 28.5¢ | 27.5¢ | 8072 | ||
| Last updated 10.23am 15/05/2024 ? | |||||
| PAR (ASX) Chart |